Ionis Pharmaceuticals IONS Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's net gains (losses) on investments?
- Ionis Pharmaceuticals (IONS) reported net gains (losses) on investments of $22.58M in Q1 2026.
- How has Ionis Pharmaceuticals's net gains (losses) on investments changed year-over-year?
- Ionis Pharmaceuticals's net gains (losses) on investments increased by 1143.6% year-over-year, from -$2.16M to $22.58M.
- What does net gains (losses) on investments mean?
- The net profit or loss from the company's investment portfolio.
- How do you interpret net gains (losses) on investments?
- Positive values indicate successful investment performance, while negative values reflect market volatility or poor investment choices.
- How does net gains (losses) on investments compare across companies?
- Standard metric for companies with significant investment portfolios or strategic equity stakes.